Home › Overweight › North Carolina › Wilmington
Overweight clinical trials in Wilmington, NC
11 studies for Overweight are looking for participants at sites in and around Wilmington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
RecruitingPhase 2
- Accellacare - Tradd Court - Wilmington /ID# 282200, Wilmington
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
RecruitingPhase 2
- TMA Headlands, Wilmington
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
RecruitingPhase 3
- Accellacare and KDCILM, LLC, Wilmington
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RecruitingPhase 3
- Trial Management Associates - Wilmington - Floral Parkway, Wilmington
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RecruitingPhase 3
- Accellacare - Wilmington, Wilmington
- Jeffrey Coleman, OD, Wilmington
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecruitingPhase 3
- Trial Management Associates - Wilmington - Floral Parkway, Wilmington
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
RecruitingPhase 3
- Accellacare - Wilmington - 1917 Tradd Court, Wilmington
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
RecruitingPhase 3
- KDCILM, LLC & Accellacare US, Inc., Wilmington
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RecruitingPhase 3
- Accellacare Research of Wilmington, Wilmington
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
RecruitingPhase 3
- ACCOMPLISH-1 Research Site, Wilmington
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
RecruitingPhase 1
- Accellacare, Wilmington
Overweight trials in other cities
- San Antonio, TX34 studies
- Houston, TX33 studies
- Chicago, IL28 studies
- Orlando, FL27 studies
- Las Vegas, NV23 studies
- Miami, FL23 studies
- Atlanta, GA20 studies
- Dallas, TX20 studies
- New York City, NY19 studies
- Jacksonville, FL19 studies
- Washington, DC19 studies
- Austin, TX18 studies
Other studies in Wilmington
- Obesity15 studies
- Type 2 Diabetes8 studies
- Heart Failure6 studies
- Ulcerative Colitis4 studies
- High Blood Pressure3 studies
- Cardiovascular Disease3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.